Sunday, October 5, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Sweetgreens Impressive Performance in Q4 2023

Elaine Mendonca by Elaine Mendonca
March 1, 2024
in Breaking News
0
Financial literacy and school
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter

Sweetgreen’s Strong Performance in Q4 2023
___________________________________________________
On February 29, 2024, Sweetgreen (NYSE: SG) released its fourth-quarter 2023 financial results, which surpassed expectations. The company reported a quarterly loss of $(0.240) per share, outperforming the analyst consensus estimate of $(0.260) by 7.69%. This represents a 45.45% improvement compared to the same period last year when losses were $(0.440) per share. Sweetgreen also reported quarterly sales of $153.026 million, exceeding the analyst consensus estimate of $152.128 million by 0.59%. This indicates a substantial 29.06% increase in sales compared to the previous year.
___________________________________________________
The total revenue for the quarter amounted to $153.4 million, demonstrating significant growth from $124.0 million in the prior year period. Sweetgreen’s core values center around creating healthier communities through real food and transparent supply chains. The company’s dedication to quality ingredients and community involvement has played a key role in its market success.
___________________________________________________
In conclusion, Sweetgreen’s Q4 2023 financial results showcase a positive trajectory with better-than-expected earnings per share and sales figures, highlighting growth and resilience in the competitive food industry landscape.

SG Stock Shows Strong Performance with 2.74% Rise on February 29, 2024

On February 29, 2024, SG stock showed strong performance, with the price of shares increasing by $0.34 since the market last closed. This represents a significant 2.74% rise, closing at $12.74. Additionally, in after-hours trading, the stock continued to climb, rising by an impressive $1.76.

SG is currently trading in the middle of its 52-week range and is above its 200-day simple moving average. This indicates that the stock has been showing positive momentum and may continue to perform well in the near future.

Investors and analysts will be keeping a close eye on SG stock to see if this upward trend continues. The strong performance on February 29th has certainly caught the attention of many in the market, and the after-hours trading activity suggests that there is continued interest and confidence in the stock.

It will be interesting to see how SG stock performs in the coming days and weeks, as investors look for opportunities to capitalize on this positive momentum. As always, it is important for investors to conduct their own research and due diligence before making any investment decisions.

SG Stock Performance Analysis: Revenue Growth but Net Income Decline on February 29, 2024

On February 29, 2024, SG stock showed mixed performances based on the latest financial data. The company reported a total revenue of $470.11 million for the past year, which represents a significant increase of 38.32% compared to the previous year. However, the total revenue remained flat at $153.43 million for the last quarter.

In terms of net income, SG reported a loss of $190.44 million for the past year, indicating a decrease of 24.33% compared to the previous year. On a positive note, the net income improved slightly to -$25.05 million for the last quarter, showing an increase of 8.08% from the previous quarter.

Earnings per share (EPS) for SG stock also showed a decline over the past year, with a reported EPS of -$1.73, representing a decrease of 23.45% compared to the previous year. However, there was a slight improvement in EPS for the last quarter, with a reported EPS of -$0.22, showing an increase of 8.56% from the previous quarter.

Overall, SG stock displayed a mix of positive and negative performances on February 29, 2024. While the company saw significant growth in total revenue compared to the previous year, the net income and EPS figures showed a decline over the same period. Investors may want to closely monitor the company’s financial performance in the coming quarters to assess its long-term sustainability and growth potential.

Tags: SG
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Insuring Better Health: How Insurance Acceptance is Changing Diabetes Care

Insuring Better Health: How Insurance Acceptance is Changing Diabetes Care

Amneal Pharmaceuticals Reports Strong Financial Results for 2023 Sets Ambitious Goals for 2024

EEFT stock news

Analyst Ratings and Price Targets for Definitive Healthcare

Recommended

Banking Markets and money

Analyst Raises Price Target for Customers Bancorp Signaling Optimistic Outlook for Growth

2 years ago
Oracle Stock

Oracle’s AI Ambitions Fuel Wall Street’s Divided Outlook

3 days ago
DrugRetailers Stock Bull Market

Digital Brands Group Inc Announces Financial Projections and Commitment to Shareholder Growth in 2024

2 years ago
First Business Services Stock

Regional Bank’s Shares Test Key Support Level

4 days ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD Apple BA BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power Red Cat Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Clinical Breakthrough Fuels Spero Therapeutics Rally

Veritiv Accelerates Expansion Strategy with Strategic Acquisitions

Bright Green Shares Frozen in Place Amid Bankruptcy Proceedings

Aethlon Medical Navigates Turbulent Period with Capital Raise and Patent Developments

XRP’s Pivotal Moment: Institutional Momentum Builds for Major Breakout

Austrian Steel Giant’s Stock Surge Defies Industry Downturn

Trending

Viking Therapeutics Stock
Analysis

Viking Therapeutics Stock Surges on Acquisition Speculation

by Felix Baarz
October 5, 2025
0

Viking Therapeutics shares are experiencing a substantial upward trend, with Friday's trading session delivering a 6.60% gain...

Apple Stock

Apple Faces Investor Skepticism Over Foldable iPhone Prospects

October 5, 2025
Bioatla Inc Stock

BioAtla Shares Surge on Promising Clinical Trial Data

October 5, 2025
Spero Therapeutics Stock

Clinical Breakthrough Fuels Spero Therapeutics Rally

October 5, 2025
Veritiv Stock

Veritiv Accelerates Expansion Strategy with Strategic Acquisitions

October 5, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Viking Therapeutics Stock Surges on Acquisition Speculation
  • Apple Faces Investor Skepticism Over Foldable iPhone Prospects
  • BioAtla Shares Surge on Promising Clinical Trial Data

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com